JP2023535453A5 - - Google Patents
Info
- Publication number
- JP2023535453A5 JP2023535453A5 JP2023504746A JP2023504746A JP2023535453A5 JP 2023535453 A5 JP2023535453 A5 JP 2023535453A5 JP 2023504746 A JP2023504746 A JP 2023504746A JP 2023504746 A JP2023504746 A JP 2023504746A JP 2023535453 A5 JP2023535453 A5 JP 2023535453A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- aryl
- heteroaryl
- pharmaceutically acceptable
- stereoisomer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063056168P | 2020-07-24 | 2020-07-24 | |
| US63/056,168 | 2020-07-24 | ||
| US202063113557P | 2020-11-13 | 2020-11-13 | |
| US63/113,557 | 2020-11-13 | ||
| PCT/US2021/042999 WO2022020730A1 (en) | 2020-07-24 | 2021-07-23 | Quinazolinone hsd17b13 inhibitors and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023535453A JP2023535453A (ja) | 2023-08-17 |
| JP2023535453A5 true JP2023535453A5 (cg-RX-API-DMAC7.html) | 2024-07-18 |
Family
ID=79728363
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023504746A Pending JP2023535453A (ja) | 2020-07-24 | 2021-07-23 | キナゾリノンhsd17b13阻害剤とその使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230286923A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4185380A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2023535453A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230066554A (cg-RX-API-DMAC7.html) |
| CN (1) | CN116194440A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021310936A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3186951A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL300107A (cg-RX-API-DMAC7.html) |
| TW (1) | TW202220964A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022020730A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IN202011027502A (cg-RX-API-DMAC7.html) * | 2020-06-29 | 2021-12-31 | Council Scient Ind Res | |
| JP2023537271A (ja) | 2020-07-24 | 2023-08-31 | イニファーム,インク. | チオフェンhsd17b13阻害剤とその使用 |
| CN116670118B (zh) | 2020-11-13 | 2026-02-06 | 伊尼制药公司 | 二氯苯酚hsd17b13抑制剂及其用途 |
| US12617772B2 (en) * | 2021-04-05 | 2026-05-05 | Inipharm, Inc. | Hydroxypyridine HSD17B13 inhibitors and uses thereof |
| CA3229569A1 (en) | 2021-08-20 | 2023-02-23 | Enanta Pharmaceuticals, Inc. | 17-beta-hydroxysteroid dehydrogenase type 13 inhibitors and methods of use thereof |
| WO2023192375A1 (en) * | 2022-03-29 | 2023-10-05 | Fl2022-001, Inc. | Hsd17b13 inhibitors and uses thereof |
| CN114644655B (zh) * | 2022-04-19 | 2023-10-27 | 湖南农业大学 | 一种光催化磷酰化喹唑啉酮类化合物的制备方法 |
| IL315794A (en) * | 2022-04-28 | 2024-11-01 | Enanta Pharm Inc | Pyrimidine containing 17-beta-hydrosteroid dehydrogenase type 13 inhibitors |
| HRP20251564T1 (hr) * | 2022-05-19 | 2026-01-30 | Astrazeneca Ab | Amidni heteroaromatski spojevi korisni u liječenju bolesti jetre |
| US20250340546A1 (en) | 2022-06-09 | 2025-11-06 | Boehringer Ingelheim International Gmbh | Hsd17b13 inhibitors |
| WO2025024682A1 (en) * | 2023-07-26 | 2025-01-30 | Inipharm, Inc. | Methods of using dichlorophenol hsd17b13 inhibitors |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2694711A (en) * | 1952-12-02 | 1954-11-16 | American Cyanamid Co | Quinazolone antimalarial compounds |
| JP2005097276A (ja) * | 2003-08-22 | 2005-04-14 | Takeda Chem Ind Ltd | 縮合ピリミジン誘導体およびその用途 |
| US20070010537A1 (en) * | 2004-08-20 | 2007-01-11 | Kazumasa Hamamura | Fused pyramidine derivative and use thereof |
| US20090163521A1 (en) * | 2005-06-28 | 2009-06-25 | Orchid Research Laboratories Limited | Novel Pyrazolopyrimidinone Derivatives |
| HUE035389T2 (en) * | 2006-09-26 | 2018-05-02 | Celgene Corp | 5-substituted quinazolinone derivatives as anticancer agents |
| US20080255161A1 (en) * | 2007-04-11 | 2008-10-16 | Dmitry Koltun | 3-HYDROQUINAZOLIN-4-ONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORS |
| US20120165330A1 (en) * | 2010-12-22 | 2012-06-28 | Sirtris Pharmaceuticals, Inc. | Quinazolinone and related analogs as sirtuin modulators |
| AU2014205043B2 (en) * | 2013-01-14 | 2018-10-04 | Deuterx, Llc | 3-(5-substituted-4-oxoquinazolin-3(4h)-yl)-3-deutero-piperidine-2,6-dione derivatives |
| WO2016081522A1 (en) * | 2014-11-17 | 2016-05-26 | Rhode Island Hospital | Nanomaterial compositions, synthesis, and assembly |
| EP3404024B1 (en) * | 2016-01-14 | 2020-11-18 | Kangpu Biopharmaceuticals, Ltd. | Quinazolinone derivative, preparation method therefor, pharmaceutical composition, and applications |
-
2021
- 2021-07-23 CN CN202180065725.7A patent/CN116194440A/zh active Pending
- 2021-07-23 IL IL300107A patent/IL300107A/en unknown
- 2021-07-23 WO PCT/US2021/042999 patent/WO2022020730A1/en not_active Ceased
- 2021-07-23 KR KR1020237006628A patent/KR20230066554A/ko not_active Ceased
- 2021-07-23 JP JP2023504746A patent/JP2023535453A/ja active Pending
- 2021-07-23 AU AU2021310936A patent/AU2021310936A1/en not_active Abandoned
- 2021-07-23 TW TW110127238A patent/TW202220964A/zh unknown
- 2021-07-23 US US18/006,062 patent/US20230286923A1/en not_active Abandoned
- 2021-07-23 CA CA3186951A patent/CA3186951A1/en active Pending
- 2021-07-23 EP EP21845951.9A patent/EP4185380A4/en not_active Withdrawn